Scorpions show a refractory period that lasts until both paraxial
organs have regenerated their contents.
The propagation of beam through paraxial
periodic slab system with NIMs can be described by the Collins integral :
Vivarelli et al., "Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial
mesoderm and the later activation of myogenesis in the absence of Myf5," Development, vol.
Operand Meaning Target [T.sub.1] Effective focal length 2 mm [T.sub.2] Total length 4 mm [T.sub.3] Paraxial
image height 2.3mm [T.sub.4] Relative illumination 55% [T.sub.5] Maximum center thickness of the glass 1 mm [T.sub.6] Minimum center thickness of the glass 0.3 mm [T.sub.7] Maximum edge thickness of the glass 1 mm [T.sub.8] Minimum edge thickness of the glass 0.3 mm [T.sub.9] Distortion max 15% Table 5: Lens parameter table after optimization.
Gutierrez-Vega, "Ince-Gaussian modes of the paraxial
wave equation and stable resonators," Journal of the Optical Society of America A, vol.
Therefore, by employing the augmented 5 x 5 ray matrix method, beam behavior in our multipass systems (also called UMS) can be modeled in the paraxial
approximation domain (incident angle less than 5 degrees).
Subsequently, many other scholars proposed other boundary conditions, including the rigid transmitting boundary , the iterative transmitting boundary , the Smith boundary , the paraxial
boundary [15, 16], and the Higdon boundary .
view demonstrating the close relation (1 mm) of the pericardiophrenic bundle (arrow) to the right upper pulmonary vein (RUPV).
 suggest that the spinal defect in Noggin null embryos results from a failure to maintain a closed neural tube due to a defective paraxial
The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial
Using the paraxial
approximation, by considering that the dimensions [x.sub.1], [y.sub.1] of output plane are much smaller than the distance z of propagation, r can be rewritten by means of a Taylor series expansion as r = z + [([x.sub.1] - [x.sub.0]).sup.2]/2z + [([y.sub.1] - [y.sub.0]).sup.2]/2z.
BASEL, Switzerland, June 8, 2016--CRISPR Therapeutics and French company Anagenesis Biotechnologies (Illkirch) announced a strategic inlicensing and collaboration agreement that grants CRISPR a license to Anagenesis' proprietary Paraxial
Mesoderm Multipotent Cells (P2MCs) technology for cell therapy for all human muscle diseases.